After IL-6R antibody treatment for 10 weeks, the anti-IL6R-treated Apcmin/+Mlkl-/-mice exhibited fewer intestinal polyps than the UT Apcmin/+Mlkl-/-group (Figure 5C and Figure S5A). The gene discussed is MLKL; the disease is intestinal polyp.